Evidence map›Paper›PMID 27281059›Full record

ArticleAIDS (London, England)2016

Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy.

Yean K Yong, Esaki M Shankar, Ajantha Solomon, Tim Spelman, Christopher K Fairley, Julian H Elliott, Jennifer Hoy, Paul U Cameron, Adeeba Kamarulzaman, Sharon R Lewin

Open access · greenAbstract read
In one paragraph

Article in AIDS (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Frontiers in pharmacology · 2021
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yean K YongaCentre of Excellence for Research in AIDS (CERiA) bTropical Infectious Diseases Research and Education Centre (TIDREC), Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia cThe Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital dCentre of Population Health, Burnet Institute eSchool of Public Health and Preventive Medicine, Monash University fMelbourne Sexual Health Centre, Alfred Hospital gCentral Clinical School, Monash University hDepartment of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia iInfectious Disease Unit, University Malaya Medical Centre, University of Malaya, Lembah Pantai, 50603 Kuala Lumpur, Malaysia jCentre for Biomedical Research, Burnet Institute, Melbourne, Australia.
Esaki M Shankar
Ajantha Solomon
Tim Spelman
Christopher K Fairley
Julian H Elliott
Jennifer Hoy
Paul U Cameron
Adeeba Kamarulzaman
Sharon R Lewin
Monash University · AUPeter Doherty Institute · AU

Funding

Viral reservoirs and sanctuaries in HAART - treated patients: role and mechanismsU19AI096109 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCHACKER, TIMOTHY W · 2011 to 2015
$29.5M
NIAID NIH HHS U19 AI096109
6 · The paper itself

Abstract

backgroundChronic HIV infection leads to marked depletion of CD4 T cells in the gastrointestinal tract and increased microbial translocation measured by an increase in circulating lipopolysaccharide (LPS) levels. Here, we hypothesized that single-nucleotide polymorphisms (SNPs) in genes encoding the Toll-like receptor 4 (TLR4) and CD14, the principal receptors for LPS, were associated with CD4 T-cell recovery postantiretroviral therapy (ART).

methodsProspective study of predominantly white HIV-infected participants receiving suppressive ART for at least 12 months. We analysed the CD14 SNPs C-260T and the TLR4 SNPs A+896G, C+1196T. We also determined the levels of LPS and soluble CD14 in plasma samples collected pre-ART and post-ART initiation. CD4 T-cell recovery was assessed by linear mixed models.

resultsFollowing ART, individuals with a TT genotype compared with a CT or CC genotype for CD14 C-260T SNP showed higher levels of soluble CD14 (P = 0.008 and 0.003, respectively). The CC genotype for the CD14 C-260T SNP, compared with CT or TT, and the TLR4 SNP (AC/GT), compared with the homozygous genotype (AA/CC), were both independently associated with enhanced long-term CD4 T-cell recovery (>3 months; P < 0.001).

conclusionPolymorphisms in CD14 and TLR4 are independently associated with long-term CD4 T-cell recovery in HIV-infected individuals post-ART.

Indexed as

Immune ReconstitutionAdultAnti-Retroviral AgentsCD4-Positive T-LymphocytesFemaleHIV InfectionsHumansLipopolysaccharide ReceptorsMaleMiddle AgedProspective StudiesToll-Like Receptor 4Anti-Retroviral AgentsLipopolysaccharide ReceptorsTLR4 protein, humanToll-Like Receptor 4

Identifiers

PMID27281059
PMCPMC5007213
OpenAlexW2416872168

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.